Abstract Herein, we report low-cost and stable CuO NPs from the Cu(II)-Schiff base complexes (Cu(II)-L1; Cu(II)-(3-((E)-(6-(trifluoromethoxy)benzo[d]thiazol-2-ylimino)methyl)benzene-1,2-diol, Cu(II)-L2; Cu(II)-(2-((E)-(6-(trifluoromethoxy)benzo[d]thiazol-2-ylimino)methyl)-5-methoxyphenol, and Cu(II)-L3; Cu(II)-(2-((E)-(6-(trifluoromethoxy)benzo[d]thiazol-2-ylimino)methyl)-4-bromophenol) via thermal decomposition method using an electric muffle furnace at 650 °C for 2 h. CuO NPs were characterized by XRD, TEM, UV–vis DRS, PL, and FTIR to investigate the phase, structure, morphological, and optical properties. It was found that the CuO NPs has a monoclinic phase with approximately 15–25 nm size in a spherical shape. The prepared CuO NPs exhibited more than 99% catalytic conversion in the reduction of 4-NP using NaBH4 in 12 min of reaction time. The evaluation of pseudo-first-order rate constants in the reduction of 4-NP was also investigated. Moreover, CuO NPs can be reused for 5 cycles without significant loss of catalytic activity. In addition, CuO NPs were found as antioxidant and antimicrobial agents, these are evaluated by DPPH scavenging and paper disc methods, respectively.
Facile thermal fabrication of CuO nanoparticles from Cu(II)-Schiff base complexes and its catalytic reduction of 4-nitrophenol, antioxidant, and antimicrobial studies
Published 2019 in Chemical Data Collections
ABSTRACT
PUBLICATION RECORD
- Publication year
2019
- Venue
Chemical Data Collections
- Publication date
2019-10-01
- Fields of study
Medicine, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-39 of 39 references · Page 1 of 1
CITED BY
Showing 1-25 of 25 citing papers · Page 1 of 1